ReviewJournal of International Society of Preventive & Community Dentistry
Effectiveness of Clear Aligner Therapy in Maxillary Molar Distalization for Class II Malocclusion: A Systematic Review of Clinical Studies.
Review in Journal of International Society of Preventive & Community Dentistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Three-dimensional finite element analysis of bracketless clear aligner expansion with different buccal bone plate thicknesses.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Addressing skeletal Class II (CII) malocclusion often involves molar distal movement (Dx). While traditional methods like headgear face challenges related to patient compliance, clear aligner therapy (CAT) is considered an appealing alternative, although its effectiveness in molar Dx is an ongoing study area. This systematic review (SR) seeks to review the recent studies on the efficacy of CAT for effecting molar Dx. The aim of this SR was to assess the effectiveness of CAT in achieving molar Dxs in individuals with sagittal CII malocclusion. Materials and Methods: A comprehensive search in five electronic databases (Scopus, PubMed, Google Scholar, Cochrane, and Web of Science) for relevant articles till December 2023 was performed. The population, intervention, comparision, outcome and study design criteria included subjects with CII malocclusion intervened with CAT, the control was no treatment or fixed appliance therapy using traditional methods of molar distalization, and the outcomes assessed were molar Dx, achieved vs. predicted movements, molar tipping, and rotation. Only prospective trials, retrospective studies, randomized controlled trials (RCTs), and controlled clinical trials were included. The principal measure of Dx was millimeters. The risk of bias (ROB) assessment of the included studies was conducted using the Newcastle-Ottawa scale and ROBINS-I tool. Preferred reporting items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines were adopted for data reporting and synthesis. The SR was registered in the PROSPERO database (registration number CRD42024531205). Results: Out of 547 studies identified, 11 papers were included in the present SR. Eight of them were retrospective, and three were prospective studies. The sample size ranged from a minimum of seven to 49 patients. A total of 278 patients were assessed in all the studies. Invisalign Conclusion: The available moderate-quality evidence suggests that CAT can achieve molar Dx up to 2 mm with good accuracy. However, the included studies were mainly retrospective with lesser samples without adequate controls; also, there was a wide variation in measurement methods and evaluation times. Well-designed RCTs are required to validate these findings and provide more robust evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.